# Mapping Draining Lymph Nodes in CNS Malignancies

> **NCT04096716** · PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 14 (actual)

## Conditions studied

- Central Nervous System Neoplasms
- Central Nervous System Tumor

## Interventions

- **DRUG:** Tc-99m tilmanocept

## Key facts

- **NCT ID:** NCT04096716
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-03
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Insufficient funding/staff
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096716, "Mapping Draining Lymph Nodes in CNS Malignancies". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04096716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*